During the past decade, Saint John's Clinic-Rolla-Cancer and Hematology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 23 clinical trials were completed, i.e. on average, 766.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint John's Clinic-Rolla-Cancer and Hematology" #1 sponsor was "SWOG Cancer Research Network" with 16 trials, followed by "National Cancer Institute (NCI)" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Eastern Cooperative Oncology Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint John's Clinic-Rolla-Cancer and Hematology" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "Roche-Genentech" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Saint John's Clinic-Rolla-Cancer and Hematology" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "Adenocarcinoma of the Gastroesophageal Junction" (3 trials), "Breast Cancer" (3 trials) and "Gastric Cancer" (2 trials). Many other conditions were trialed in "Saint John's Clinic-Rolla-Cancer and Hematology" in a lesser frequency.

Most popular intervention types in "Saint John's Clinic-Rolla-Cancer and Hematology" are "Drug" (26 trials), "Other" (19 trials), "Biological" (7 trials), "Procedure" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Docetaxel" (4 trials), "placebo" (4 trials), "Doxorubicin" (3 trials) and "Akt Inhibitor MK2206" (2 trials). Other intervention names were less common.

The vast majority of trials in "Saint John's Clinic-Rolla-Cancer and Hematology" are 24 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Saint John's Clinic-Rolla-Cancer and Hematology". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Saint John's Clinic-Rolla-Cancer and Hematology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Saint John's Clinic-Rolla-Cancer and Hematology, 1 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".